News | September 17, 2025
HCG Manavata launches awareness campaign for prostate cancer
Encouraging early detection and breaking the silence around men’s health
Encouraging early detection and breaking the silence around men’s health
The company is bringing precision therapies for gynaecological cancers
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
Addresses brain metastases harboring BRCA1/2 and/or HRR alterations—an area of high unmet need
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
Aumolertinib can be used in patients who have tested positive for a mutation in a gene called epidermal growth factor receptor
MANEUVER met all five key secondary endpoints, with statistically significant and clinically meaningful improvements in pain, stiffness, range of motion, physical function, and decrease in tumor volume
Approval brings AstraZeneca and Daiichi Sankyo’s Enhertu earlier in the treatment of HR-positive, HER2-low breast cancer and broadens the eligible patient population to those with HER2-ultralow disease
Positions Curium as leading manufacturer of Lu-177 isotope
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Subscribe To Our Newsletter & Stay Updated
